CASE REPORT
Ultrasound-guided Perineural Dextrose Injection for Treatment of Superior Cluneal Nerve Entrapment: Serial Case Report
Yusak M. T. Siahaan1, 2, *, Jessica Herlambang2, Cynthia Putri2, Pamela Tiffani2
Article Information
Identifiers and Pagination:
Year: 2021Volume: 14
First Page: 32
Last Page: 37
Publisher ID: TOPAINJ-14-32
DOI: 10.2174/1876386302114010032
Article History:
Received Date: 05/4/2021Revision Received Date: 24/6/2021
Acceptance Date: 05/8/2021
Electronic publication date: 17/11/2021
Collection year: 2021
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Background:
Superior cluneal nerve entrapment is a neuropathic condition caused by the inclusion of the superior cluneal nerve that contributes to one of the causes of lower back pain leading to high morbidity. Several therapeutic modalities
are available for superior cluneal nerve entrapment, including medications, physiotherapy, perineural injection, and surgery. Perineural injection with 5% dextrose has become therapeutic alternative in many cases of neuropathy, but its long-term effectiveness is unknown.
Case Presentation:
This study described four patients with superior cluneal nerve entrapment with severe pain intensity treated with ultrasonography guided perineural 5% dextrose injection, resulting in significant clinical improvement during the 6-month evaluation.
Conclusion:
Perineural injection can be considered as long-term therapy in patients with superior cluneal nerve entrapment who have failed other conventional therapies.
